The Effect of Red Blood Cells Storage Duration on Biochemical Changes in Pediatric Patients

NCT ID: NCT02724605

Last Updated: 2018-01-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-01-31

Study Completion Date

2017-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to detect if the storage duration of red blood cells has impact on some biochemical parameters after intra operative transfusion in pediatric trauma patient

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

* A pretransfusion draw of a few drops of patient venous blood, send for analysis by i-STAT Portable Clinical Analyser. Samples are processed immediately and provide laboratory quality results in 2 minutes using the CHEM 8+ i-STAT cartridge for measurement of:

1. Potassium (K)
2. Ionized Calcium (iCa)
3. Glucose (Glu)
4. Urea Nitrogen (BUN)/Urea
5. Hemoglobin (Hb) and Hematocrit (Hct).
* Concurrently, a few drops of blood will be taken from the unit to be transfused will be analysed by i-STAT Portable Clinical Analyser for measurement of previous biochemical parameters.
* The details of the unit, such as draw date, volume of transfusion, and date of transfusion, will be recorded. The RBC unit will be delivered to the operative room from the blood bank in an insulated box.
* The transfusion is then given as clinically indicated at a rate of 50 to 150 mL/h based on the clinician's orders, the patient's weight, and the patient's clinical situation.
* Volumes will be transfused to children according to the following top-up transfusion equation: desired Hemoglobin (Hb) (g/dl) - actual Hemoglobin (Hb) (g/dl) x weight (kg) x 3. (usually 10-20 ml/kg).
* A second patient blood sample will be drawn one hour after the transfusion and will be analyzed by i-STAT Portable Clinical Analyser.
* Patient information will be recorded for age, weight, sex, and primary diagnosis.
* Demographic and clinical variables will be collected, to include type and quantity of all blood products and fluids received and medications administered. All surgical procedures will be documented.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Red Blood Cells Transfusion

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A

Red blood cells unit age 14 days or less

Group Type OTHER

Red blood cells unit age 14 days or less

Intervention Type BIOLOGICAL

30 Patients who will receive units of packed red blood cells stored stored for 14 days or less

Group B

Red blood cells unit age more than 14 days

Group Type OTHER

Red blood cells unit age more than 14 days

Intervention Type BIOLOGICAL

30 patients who will receive units of packed red blood cells stored for more than 14 days

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Red blood cells unit age 14 days or less

30 Patients who will receive units of packed red blood cells stored stored for 14 days or less

Intervention Type BIOLOGICAL

Red blood cells unit age more than 14 days

30 patients who will receive units of packed red blood cells stored for more than 14 days

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

.ASA I-II physical status patients.

* Genders Eligible for Study : both .
* Age: 2\_10 years
* All non-crush trauma pediatric patients need intraoperative RBC transfusion.
* RBCs transfusion Volume within 10-20ml/kg.

Exclusion Criteria

* Patients with renal failure (serum creatinine 1.5 mg/dL)
* Hepatic insufficiency.
* Furosemide diuresis.
* Succinylcholine for rapid sequence induction.
* Electrolytes disorders.
Minimum Eligible Age

2 Years

Maximum Eligible Age

10 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role collaborator

Abdelrady S Ibrahim, MD

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Abdelrady S Ibrahim, MD

Assistant professor of Anesthesia and Intensive care

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Abdelrady S Ibrahim

Role: PRINCIPAL_INVESTIGATOR

Assistant professor of anesthesia and intensive care

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Assiut university faculty of medicine

Asyut, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

References

Explore related publications, articles, or registry entries linked to this study.

Qu L, Triulzi DJ. Clinical effects of red blood cell storage. Cancer Control. 2015 Jan;22(1):26-37. doi: 10.1177/107327481502200105.

Reference Type BACKGROUND
PMID: 25504276 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB0000871236

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Red Cell Storage Duration Study
NCT00991341 COMPLETED PHASE3
Cold Apheresis Platelets in PAS
NCT02754414 UNKNOWN PHASE1
Tranexamic Acid Effect in Pediatric
NCT06097611 NOT_YET_RECRUITING EARLY_PHASE1